Why Compare Mounjaro And Wegovy Doses Before Buying?
Understanding Mounjaro And Wegovy Doses For UK Buyers
When comparing Mounjaro and Wegovy doses online, the key difference lies in their dosing mechanisms and frequency. Wegovy follows a structured 20-week escalation from 0.25mg to 2.4mg maintenance, while Mounjaro escalates over 20 weeks from 2.5mg to 15mg maximum maintenance. Both treatments require careful dose escalation to minimise side effects, but their different active ingredients mean the dosing schedules cannot be directly compared. At EverydayMeds, we provide clear guidance on both Mounjaro and Wegovy doses through our clinical assessment process.
The practical implications of these different Mounjaro and Wegovy doses extend to cost planning and treatment duration. Wegovy's lower microgram dosing doesn't indicate lower potency—semaglutide and tirzepatide work through different receptor pathways. Our pricing structure reflects the genuine cost of both medications, with Wegovy starting at £79.99 for the initial 0.25mg dose. Understanding these differences helps patients and prescribers make informed decisions about long-term treatment sustainability.
Wegovy Dose Pricing And Bundle Options UK
Our transparent pricing for Wegovy makes planning your treatment journey straightforward, with doses ranging from £79.99 for the 0.25mg starter to £209.99 for the 2.4mg maintenance dose. The Intro Duo bundle combines your first two doses (0.25mg and 0.5mg) for £169.99, covering your initial 8 weeks of treatment. New customers apply discount code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. Our bundle approach prioritises convenience—fewer orders, Reliable Supply continuity, and single cold-chain deliveries.
When comparing Mounjaro and Wegovy doses from a cost perspective, both medications represent significant monthly investments that require insurance or private payment in the UK. Our 3-pen Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ideal for patients established on their optimal dose. Bundle pricing eliminates the uncertainty of individual dose ordering while ensuring you never run out during critical treatment phases. Express prescriber reviews are available for £25 additional, reducing approval times from 3 working days to 24 hours.
Clinical Evidence Behind Mounjaro And Wegovy Doses
The STEP clinical trial programme established Wegovy's dosing protocol through rigorous testing across different patient populations. In STEP 1, patients taking Wegovy 2.4mg alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). These results informed the current dose escalation schedule designed to optimise efficacy while managing tolerability.
Mounjaro's SURMOUNT trials demonstrated the effectiveness of tirzepatide's dual GIP/GLP-1 receptor approach across its dosing range. When comparing clinical outcomes between Mounjaro and Wegovy doses, both treatments showed significant results in their respective trial programmes, though direct head-to-head comparisons remain limited. Both medications require individualised dosing based on patient response and tolerability, which our prescribers assess through ongoing clinical monitoring.
How Wegovy's GLP-1 Mechanism Determines Dose Requirements
Wegovy works as a GLP-1 receptor agonist, mimicking your body's natural incretin hormone to regulate appetite and food intake. The medication binds to GLP-1 receptors in your brain's appetite control centres, promoting feelings of fullness and reducing food cravings between meals. This mechanism explains why dose escalation is essential—your body needs time to adapt to increasing GLP-1 receptor stimulation. Starting at 0.25mg allows your digestive system to adjust gradually, minimising nausea and other gastrointestinal side effects. The 2.4mg maintenance dose represents the optimal balance between efficacy and tolerability established through clinical trials, though some patients may maintain benefits at lower doses.
EverydayMeds Ordering Process For Mounjaro And Wegovy Doses
Ordering Wegovy through EverydayMeds begins with our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our UK-registered prescribers review your assessment within 3 working days (or 24 hours with express service), determining your appropriate starting dose and identifying any contraindications. Once approved, your genuine Novo Nordisk Wegovy ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Each order includes comprehensive dosing instructions, injection technique guidance, and access to our clinical support team for ongoing questions. Our GPhC-registered pharmacy (#9012878) ensures all Wegovy supplies meet MHRA quality standards with full traceability from manufacturer to patient.
Storage Differences Between Mounjaro And Wegovy Doses
Storage requirements represent a practical consideration when choosing between Mounjaro and Wegovy doses for UK patients. Both medications require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability below 30°C once removed from the fridge. Mounjaro provides 21 days room temperature stability, still adequate for most travel scenarios but less forgiving for extended trips. The FlexTouch pen delivery system used by Wegovy includes clear dose windows and audible click confirmations, making accurate dosing straightforward across all dose strengths. Both medications should never be frozen, shaken vigorously, or exposed to direct sunlight during storage.
UK-Specific Considerations For Mounjaro And Wegovy Doses Online
Purchasing Mounjaro and Wegovy doses online in the UK requires navigating prescription-only medicine regulations that protect patient safety. EverydayMeds operates under strict MHRA oversight, ensuring every prescription meets clinical standards before dispensing. UK patients benefit from established NICE guidance (TA875) supporting Wegovy use in appropriate candidates, though NHS availability remains limited through specialist services. Our online model bridges this gap, providing private access with full clinical oversight and genuine manufacturer supplies.
The regulatory landscape for Mounjaro and Wegovy doses continues evolving, with new dose strengths like Wegovy 7.2mg receiving MHRA approval in January 2026. Our clinical team stays current with these developments, ensuring patients access the most appropriate doses as they become available. Both treatments require ongoing monitoring for side effects and efficacy, which our prescribers facilitate through follow-up consultations and dose adjustment recommendations.
Making Your Choice Between Mounjaro And Wegovy Doses
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your individual circumstances. Factors influencing this choice include your medical history, previous weight management attempts, injection frequency preferences, and budget considerations. Our clinical assessment captures these variables, enabling personalised recommendations rather than generic treatment approaches. Starting your weight management journey with the right medication and dose optimises your chances of long-term success. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, or speak with our clinical team about both treatment options during your consultation.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
